Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
9
6
0
0
89BIO INC Share · US2825591033 · ETNB (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of 89BIO INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 98,45 %
Shares Float 146,01 M
Shares Outstanding 148,3 M
Company Profile for 89BIO INC Share
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Company Data
Name 89BIO INC
Company 89bio, Inc.
Symbol ETNB
Website
https://www.89bio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US2825591033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Rohan Palekar
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 142 Sansome Street, 94104 San Francisco
IPO Date 2019-11-11
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | ETNB |
More Shares
Investors who hold 89BIO INC also have the following shares in their portfolio:
